IDO1 and fatty liver disease: For instance, a recent study demonstrated that neither the overexpression of IDO nor inhibition of its enzymatic activity affected the lipid accumulation in the liver, although the combination of L-tryptophan treatment and a high fat and high fructose diet exacerbated the hepatic steatosis [29].